Cho, N. M., P.-J. Chueh, C. Kim, S. Caldwell, D. M. Morré and D. J. Morré. 2002. A monoclonal antibody to a circulating form of a drug-responsive hydroquinone (NADH) oxidase from sera of cancer patients. Can. Immunol. Immunotherapy 51: 121-129.
Chueh, P.-J., D. J. Morré, F. E. Wilkinson, J. Gibson and D. M. Morré. l997b. A 33.5 kDa heat- and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients. Arch. Biochem. Biophys. 342: 38-47.
Chueh, P.-J., C. Kim, N. M. Cho, D. M. Morré and D. J. Morré. 2002. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface. Biochemistry 41: 3732-3741.
Lambeth, J.D., G. Cheng, R. S. Arnold and W. A. Edens. 2000. Novel homologs of gp91 phox. TIBS 25: 459-461.
Morré, D. J. 1995. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N-(4-chlorophenyl)urea (LY181984) at an external site. Biochim. Biophys. Acta 1240: 201-208.
Morré, D.J. and D. M. Morré. 2003. Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative disease. Free Radical Res. 37: 795-808.
Morré, D. J. and T. Reust. l997. A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LYl8l984) specific to sera of cancer patients. J. Bioenerg. Biomemb. 29: 28l-289.
Morré, D. J., S. Caldwell, A. Mayorga, L.-Y. Wu and D. M. Morré. 1997. NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients. Arch. Biochem. Biophys. 342: 224-230.
Morré, D. J., K. L. Pennington, H. Hignite, H. Orvis, D. J. Schwartzentruber, X. Tang and D. M. Morré. 2006a. Detection of blood-borne cancer using polymerase chain reaction for tNOX messenger RNA. Abstracts. 97th Annual Meeting, American Association for Cancer Research, Washington, DC, April 1-5, 2006. 2006: 1336-1337.
Morré, D. J., X. Tang, D. M. Morré, K. L. Pennington, H. Hignite, H. Orvis and D. J. Schwartzentruber. 2006b. RTPCR detection of cancer cells in blood based on presence of a tNOX splice variant mRNA. Abstracts. 4th Early Detection Research Network (EDRN) Scientific Workshop, Philadelphia, PA, March 20-22, 2006, p. 60.
Tang, X., Z. Tian, P.-J. Chueh, S. Chen, D. M. Morré and D. J. Morré. 2007. Alternative splicing as the basis for specific localization of tNOX, a unique hydroquinone (NADH) oxidase, to the cancer cell surface. Biochemistry 46: 12337-12346.
Wilkinson, F. E., C. Kim, N. Cho, P.-J. Chueh, S. Leslie, S. Moya-Camarena, L.-Y. Wu, D. M. Morré and D. J. Morré. l996. Isolation and identification of a protein with capsaicin-inhibited NADH oxidase activity from culture media conditioned by growth of HeLa cells. Arch. Biochem. Biophys. 336: 275-282.